Essilor, HPO enter exclusive global license agreement

Article

Charenton le Pont, France-Essilor has signed an exclusive and global license agreement with High Performance Optics (HPO), that complements its existing patent and technologies portfolio. This license agreement will allow Essilor to continue to focus on products with correction and preventive benefits and to roll out its portfolio of products around the world.

The pact enables Essilor to strengthen its mission of reaching the 4.2 billion people worldwide who need vision correction.

As a result of the company’s R&D and innovation processes, Essilor currently has approximately 5,600 patents throughout the world that help extend its strategy.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Related Content
While diabetic retinopathy is not one of the leading causes of blindness and vision impairment globally, the widespread prevalence of diabetes warrants the need for resources.

AOA 2025: What role do optometrists play in the diabetic pandemic?

Jordana Joy, Associate Editor
July 2nd 2025
Article
Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

June 30th 2025
Podcast
The AOA president and Board of Trustees being sworn in during the House of Delegates meeting in Minneapolis, Minnesota. Image credit: American Optometric Association

AOA inducts new Board of Trustee members, Dr Jacqueline Bowen as president

Jordana Joy, Associate Editor
July 1st 2025
Article
Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge

Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge

June 30th 2025
Podcast
Woman administering eye drops Image credit: AdobeStock/TatjanaMeininger

Bausch + Lomb's new dry eye survey data usher in campaign for patient education

Jordana Joy, Associate Editor
July 1st 2025
Article
Prevent Blindness declares July to be Dry Eye Month, provides patient resources - Image credit: ©NanSan—stock.adobe.com

Prevent Blindness declares July to be Dry Eye Month, provides patient resources

Emily Kaiser Maharjan, Assistant Managing Editor
June 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.